Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4081/monaldi.2013.91 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!